Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan

被引:14
作者
Endoh, T
Yagihashi, A
Uehara, N
Kobayashi, D
Tsuji, N
Nakamura, M
Hayashi, S
Fujii, N
Watanabe, N
机构
[1] Sapporo Med Univ, Sch Med, Dept Clin Lab Med, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
[2] Sapporo Med Univ, Sch Med, Div Lab Diag, Sapporo, Hokkaido, Japan
[3] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido, Japan
关键词
D O I
10.1017/S0950268801006744
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Thirty Japanese clinical isolates of Mycobacterium tuberculosis were analysed by pyrazinamide susceptibility testing and pyrazinamidase assay, as well as polymerase chain reaction for single-strand conformational polymorphism and direct sequencing of the gene encoding pyrazinamidase (pncA). All sensitive isolates showed pyrazinamidase activity and a wild-type pncA gene, but three resistant isolates had pncA gene mutations and lacked pyrazinamidase activity. The latter isolates showed a minimum inhibitory concentration of Lit least 100 mg/l by the 7H10 agar proportion method and 400 mg/l by the 7H9 liquid medium method. Isolate 28 showed T-to-C change at position 11, leading to Leu4 --> Ser substitution; isolate 29 had an 8-bp deletion from position 382; and isolate 30 had A-to-C change Lit position 29, leading to Gln 10 --> Pro substitution. The deletion has not been described previously. This is the first demonstration of pncA gene mutations in PZA-resistant M. tuberculosis strains isolated from Japanese patients.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 22 条
[21]  
World Health Organization, 1995, WHO REP TUB EP STOP, P270
[22]   Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis [J].
Zimhony, O ;
Cox, JS ;
Welch, JT ;
Vilchèze, C ;
Jacobs, WR .
NATURE MEDICINE, 2000, 6 (09) :1043-1047